Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.54T | 4.65T | 2.81T | 5.31T | 2.21T | 1.92T |
Gross Profit | 2.71T | 2.69T | 2.63T | 2.71T | 2.21T | 1.92T |
EBITDA | 1.70T | 1.68T | 1.79T | 1.76T | 1.05T | 667.09B |
Net Income | 1.28T | 1.25T | 1.37T | 1.45T | 792.92B | 401.63B |
Balance Sheet | ||||||
Total Assets | 53.77T | 52.06T | 55.72T | 55.26T | 51.70T | 46.10T |
Cash, Cash Equivalents and Short-Term Investments | 5.69T | 2.04T | 10.52T | 7.50T | 7.64T | 4.44T |
Total Debt | 12.48T | 9.98T | 10.47T | 10.41T | 10.09T | 9.27T |
Total Liabilities | 48.37T | 45.55T | 49.64T | 50.40T | 47.48T | 42.37T |
Stockholders Equity | 5.40T | 6.50T | 6.08T | 4.86T | 4.22T | 3.73T |
Cash Flow | ||||||
Free Cash Flow | 1.68T | 379.42B | 1.64T | -411.72B | 2.36T | 471.70B |
Operating Cash Flow | 1.74T | 396.64B | 1.73T | -333.58B | 2.43T | 519.65B |
Investing Cash Flow | 2.14T | -58.34B | -346.50B | -72.64B | -2.90T | 209.88B |
Financing Cash Flow | -3.73T | -1.56T | -1.56T | -815.23B | 1.35T | 1.46T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $12.73B | 11.20 | 16.25% | 13.51% | -8.45% | 29.39% | |
78 Outperform | $19.96B | 12.92 | 16.35% | 5.58% | 3.89% | 15.26% | |
74 Outperform | $14.76B | 11.46 | 22.07% | 7.10% | -13.16% | -8.10% | |
74 Outperform | $4.65B | 1,068.76 | 0.11% | 3.04% | -62.73% | -99.74% | |
74 Outperform | $11.35B | 10.70 | 24.02% | 5.42% | 18.54% | 65.80% | |
74 Outperform | $3.45B | 8.81 | 15.46% | 3.12% | -48.81% | 0.18% | |
58 Neutral | HK$111.68B | 6.58 | -4.20% | 3.95% | 9.04% | -46.99% |